Artelo Biosciences (ARTL) Share-based Compensation (2017 - 2025)
Artelo Biosciences (ARTL) posted quarterly Share-based Compensation of $368000.0 for Q4 2025, up 83.08% year-over-year from $201000.0 in Q4 2024, and down 14.81% quarter-over-quarter from $432000.0 in Q3 2025.
Artelo Biosciences (ARTL) Share-based Compensation (2017 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Share-based Compensation for 9 consecutive years, with $368000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Share-based Compensation rose 83.08% year-over-year to $368000.0; the TTM figure through Dec 2025 stood at $1.1 million (up 39.61% YoY), while the FY2025 annual figure was $1.1 million, up 39.61% from the prior year.
- Share-based Compensation fell to $368000.0 in Q4 2025 per ARTL's latest filing, from $432000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $624000.0 in Q1 2022 and bottomed at $150000.0 in Q2 2025.
- Historically, Share-based Compensation has averaged $352823.2 across 5 years, with a median of $283408.5 in 2021.
- Annual changes were most pronounced in 2021 — Share-based Compensation jumped 1019.61% — and 2023, when it slumped 63.98%.
- Artelo Biosciences' Share-based Compensation stood at $571000.0 in 2021, then gained by 6.48% to $608000.0 in 2022, then plunged by 63.98% to $219000.0 in 2023, then slipped by 8.22% to $201000.0 in 2024, then soared by 83.08% to $368000.0 in 2025.
- Business Quant data shows ARTL's Share-based Compensation at $368000.0 in Q4 2025, $432000.0 in Q3 2025, and $150000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 86.63 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 41.25 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 28.05 Mn |
| 10 | Artelo Biosciences | 111,698.23 | -488,301.77 | - | 368,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 368,000.00 |
| Dec 31, 2025 | 368,000.00 |
| Sep 30, 2025 | 432,000.00 |
| Sep 30, 2025 | 432,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Sep 30, 2024 | 209,000.00 |
| Sep 30, 2024 | 209,000.00 |
| Jun 30, 2024 | 195,000.00 |
| Jun 30, 2024 | 195,000.00 |
| Mar 31, 2024 | 213,000.00 |
| Mar 31, 2024 | 213,000.00 |
| Dec 31, 2023 | 219,000.00 |
| Dec 31, 2023 | 219,000.00 |
| Sep 30, 2023 | 222,000.00 |
| Sep 30, 2023 | 222,000.00 |